AAPG EBITDA

annual EBITDA:

-$46.10M+$59.02M(+56.15%)
December 31, 2024

Summary

  • As of today (August 25, 2025), AAPG annual EBITDA is -$46.10 million, with the most recent change of +$59.02 million (+56.15%) on December 31, 2024.
  • During the last 3 years, AAPG annual EBITDA has risen by +$75.82 million (+62.19%).
  • AAPG annual EBITDA is now -526.09% below its all-time high of -$7.36 million, reached on December 1, 2017.

Performance

1-year change

+56.15%

3-year change

+62.19%

5-year change

+78.06%

15-year change

-526.09%

AAPG EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

32.65%
AAPG annual EBITDA is higher than 32.65% of companies in Healthcare sector

Range

All-time high

-$7.36M

3-year low

-$121.92M

Earnings dates

Last annual earnings report date

Dec 31, 2024
AAPG previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

Mar 26, 2026
AAPG next annual earnings announcement is scheduled for Mar 26, 2026

OtherAAPGincome statement metrics

Annual revenue

$136.26M
AAPG annual revenue is $136.26 million

annual net income

-$56.37M
AAPG annual net profit is -$56.37 million

annual EBIT

-$46.10M
AAPG annual earnings before interest & taxes is -$46.10 million

Annual EPS

-$0.74
AAPG annual earnings per share is -$0.74

quarterly EBITDA:

-$6.70M-$4.50M(-205.16%)
March 31, 2018

Summary

  • As of today (August 25, 2025), AAPG quarterly EBITDA is -$6.70 million, with the most recent change of -$4.50 million (-205.16%) on March 31, 2018.
  • Over the past year, AAPG quarterly EBITDA has dropped by -$4.50 million (-205.16%).
  • AAPG quarterly EBITDA is now -205.16% below its all-time high of -$2.19 million, reached on March 31, 2017.

Performance

3-month change

0%

1-year change

-205.16%

3-year change

-205.16%

5-year change

-205.16%

AAPG quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

39.91%
AAPG quarterly EBITDA is higher than 39.91% of companies in Healthcare sector

Range

All-time high

-$2.19M

3-year low

-$6.70M
AAPG quarterly EBITDA is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2018
AAPG previous earnings announcement was published on Mar 31, 2018

Next quarterly earnings report date

Mar 26, 2026
AAPG next earnings announcement is scheduled for Mar 26, 2026

OtherAAPGincome statement metrics

Quarterly revenue

$141.20K
AAPG quarterly revenue is $141.20 thousand

quarterly net income

-$2.01M
AAPG quarterly net profit is -$2.01 million

quarterly EBIT

-$7.20M
AAPG quarterly earnings before interest & taxes is -$7.20 million

Quarterly EPS

$0.00
AAPG quarterly earnings per share is $0.00

TTM EBITDA:

-$6.70M-$4.50M(-205.16%)
March 31, 2018

Summary

  • As of today (August 25, 2025), AAPG TTM EBITDA is -$6.70 million, with the most recent change of -$4.50 million (-205.16%) on March 31, 2018.
  • Over the past year, AAPG TTM EBITDA has stayed the same.
  • AAPG TTM EBITDA is now -205.16% below its all-time high of -$2.19 million, reached on March 31, 2017.

Performance

3-month change

0%

1-year change

0%

3-year change

0%

5-year change

0%

AAPG TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

66%
AAPG TTM EBITDA is higher than 66% of companies in Healthcare sector

Range

All-time high

-$2.19M

3-year low

-$6.70M
AAPG TTM EBITDA is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2018
AAPG previous earnings announcement was published on Mar 31, 2018

Next quarterly earnings report date

Mar 26, 2026
AAPG next earnings announcement is scheduled for Mar 26, 2026

OtherAAPGincome statement metrics

TTM revenue

$141.20K
AAPG TTM revenue is $141.20 thousand

TTM net income

-$2.01M
AAPG TTM net profit is -$2.01 million

TTM EBIT

-$7.20M
AAPG TTM earnings before interest & taxes is -$7.20 million

TTM EPS

$0.00
AAPG TTM earnings per share is $0.00

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

-$46.10M
AAPG annual EBITDA is -$46.10 million

annual net income

-$56.37M
AAPG annual net profit is -$56.37 million

annual interest expense

$8.98M
AAPG annual interest expense is $8.98 million

annual income tax

$1.45M
AAPG annual income tax is $1.45 million

annual D&A

$12.98M
AAPG annual depreciation & amortization is $12.98 million

AAPG EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+56.1%-205.2%0.0%
3 y3 years+62.2%-205.2%0.0%
5 y5 years+78.1%-205.2%0.0%

AAPG EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+62.2%at highat lowat highat low
5 y5-yearat high+78.1%at highat lowat highat low
alltimeall time-526.1%+78.1%-205.2%at low-205.2%at low

AAPG EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$46.10M(-56.1%)
-
-
Dec 2023
-$105.12M(-8.5%)
-
-
Dec 2022
-$114.85M(-5.8%)
-
-
Dec 2021
-$121.92M(+31.1%)
-
-
Dec 2020
-$93.00M(-55.7%)
-
-
DateAnnualQuarterlyTTM
Dec 2019
-$210.15M(+376.5%)
-
-
Dec 2018
-$44.10M(+498.9%)
-
-
Mar 2018
-
-$6.70M(+205.2%)
-$6.70M(+205.2%)
Dec 2017
-$7.36M(-52.4%)
-
-
Mar 2017
-
-$2.19M
-$2.19M
Dec 2016
-$15.48M
-
-

FAQ

  • What is Ascentage Pharma Group International annual EBITDA?
  • What is the all time high annual EBITDA for Ascentage Pharma Group International?
  • What is Ascentage Pharma Group International annual EBITDA year-on-year change?
  • What is Ascentage Pharma Group International quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Ascentage Pharma Group International?
  • What is Ascentage Pharma Group International quarterly EBITDA year-on-year change?
  • What is Ascentage Pharma Group International TTM EBITDA?
  • What is the all time high TTM EBITDA for Ascentage Pharma Group International?
  • What is Ascentage Pharma Group International TTM EBITDA year-on-year change?

What is Ascentage Pharma Group International annual EBITDA?

The current annual EBITDA of AAPG is -$46.10M

What is the all time high annual EBITDA for Ascentage Pharma Group International?

Ascentage Pharma Group International all-time high annual EBITDA is -$7.36M

What is Ascentage Pharma Group International annual EBITDA year-on-year change?

Over the past year, AAPG annual EBITDA has changed by +$59.02M (+56.15%)

What is Ascentage Pharma Group International quarterly EBITDA?

The current quarterly EBITDA of AAPG is -$6.70M

What is the all time high quarterly EBITDA for Ascentage Pharma Group International?

Ascentage Pharma Group International all-time high quarterly EBITDA is -$2.19M

What is Ascentage Pharma Group International quarterly EBITDA year-on-year change?

Over the past year, AAPG quarterly EBITDA has changed by -$4.50M (-205.16%)

What is Ascentage Pharma Group International TTM EBITDA?

The current TTM EBITDA of AAPG is -$6.70M

What is the all time high TTM EBITDA for Ascentage Pharma Group International?

Ascentage Pharma Group International all-time high TTM EBITDA is -$2.19M

What is Ascentage Pharma Group International TTM EBITDA year-on-year change?

Over the past year, AAPG TTM EBITDA has changed by $0.00 (0.00%)
On this page